微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -3.09% | 80.87% | -147.2% | 41/56 | -10.1% | 荣昌生物 | 72.94% | 行业排名> |
| 2026-03-31 | -1.25% | 2% | 93.4% | 43/56 | -11.99% | 荣昌生物 | 8.68% | 行业排名> |
| 2025-12-31 | -18.93% | 25.53% | 22.13% | 47/56 | -3.42% | C信诺维 | 42.93% | 行业排名> |
| 2025-09-30 | -24.31% | 2% | -50.53% | 47/56 | 1.66% | 特宝生物 | 23.82% | 行业排名> |
| 2025-06-30 | -16.15% | -27.27% | 36.47% | 47/56 | -0.29% | 特宝生物 | 15.74% | 行业排名> |
| 2024-12-31 | -25.42% | -1.44% | -100.32% | 46/56 | -1.97% | 神州细胞集团公司 | 36.86% | 行业排名> |
| 2024-06-30 | -12.69% | -49.29% | 49.36% | 46/56 | 0.76% | 特宝生物 | 37.66% | 行业排名> |
| 2023-12-31 | -25.06% | -35.68% | -35.68% | 44/56 | 1.58% | 特宝生物 | 26.65% | 行业排名> |
| 2022-12-31 | -18.47% | 63.27% | -117.29% | 45/56 | -6.01% | 特宝生物 | 16.5% | 行业排名> |
| 2022-06-30 | -8.5% | 2% | 83.1% | 45/56 | 1.15% | 西藏药业 | 8.94% | 行业排名> |
| 2021-12-31 | -50.29% | 2% | 2% | 49/56 | 15.48% | 特宝生物 | 35.44% | 行业排名> |